Lupus Nephritis

Displaying 1 - 6 of 6CSV
Dall’Era, M., Kalunian, K., Solomons, N., Truman, M., Hodge, L. S., Yap, E., & Askanase, A. D. (2024). Comparison of a voclosporin-based triple immunosuppressive therapy to high-dose glucocorticoid-based immunosuppressive therapy: a propensity analysis of the AURA-LV and AURORA 1 studies and ALMS. Lupus Science & Medicine, 11(2), e001319. https://doi.org/10.1136/lupus-2024-001319
Publication Date
Zisa, D., Zhang-Sun, J., Christos, P. J., & Kirou, K. A. (2024). Sustained depression of B cell counts in lupus nephritis after treatment with rituximab and/or belimumab is associated with fewer disease flares. Lupus, 33(9), 938–947. https://doi.org/10.1177/09612033241260283
Publication Date
Gartshteyn, Y., Geraldino-Pardilla, L., Khalili, L., Bukhari, S., Lerrer, S., Winchester, R. J., Askanase, A. D., & Mor, A. (2024). SAP-expressing T peripheral helper cells identify systemic lupus erythematosus patients with lupus nephritis. Frontiers in Immunology, 15. https://doi.org/10.3389/fimmu.2024.1327437
Publication Date
Shao, D., Pena, O., Sekulic, M., Valdez Imbert, R., Vegivinti, C. T. R., & Jim, B. (2023). Secondary haemophagocytic lymphohistiocytosis in a patient with new-onset systemic lupus erythematosus: the challenges of timely diagnosis and successful treatment. BMJ Case Reports, 16(7), e252938. https://doi.org/10.1136/bcr-2022-252938
Publication Date
Stotter, B. R., Cody, E., Gu, H., Daga, A., Greenbaum, L. A., Duong, M. D., Mazo, A., Goilav, B., Boneparth, A., Kallash, M., Zeid, A., Seeherunvong, W., Scobell, R. R., Alhamoud, I., Carter, C. E., Shah, S., Straatmann, C. E., Dixon, B. P., Cooper, J. C., … Wenderfer, S. E. (2022). Acute kidney injury requiring kidney replacement therapy in childhood lupus nephritis: a cohort study of the Pediatric Nephrology Research Consortium and Childhood Arthritis and Rheumatology Research Alliance. Pediatric Nephrology, 38(5), 1653–1665. https://doi.org/10.1007/s00467-022-05775-z
Publication Date
van Vollenhoven, R., Askanase, A. D., Bomback, A. S., Bruce, I. N., Carroll, A., Dall’Era, M., Daniels, M., Levy, R. A., Schwarting, A., Quasny, H. A., Urowitz, M. B., Zhao, M.-H., & Furie, R. (2022). Conceptual framework for defining disease modification in systemic lupus erythematosus: a call for formal criteria. Lupus Science & Medicine, 9(1), e000634. https://doi.org/10.1136/lupus-2021-000634
Publication Date